Organon & Co.
OGN
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzysā¦ read more
Healthcare
Drug ManufacturersāGeneral
4 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$7.53
Price-1.18%
-$0.09
1Y
Price
Market Cap
$1.958b
Small
Price/Earnings 3y Avg5y Avg
3.9x
Premium
Premium
Financials Overview
Key metrics over the past few years+28.2%
EBITDA Margin+9.1%
Net Profit Margin+1.4%
Free Cash Flow MarginRevenue
$6.281b
-1.9%
1y CAGR+0.6%
3y CAGR-0.1%
5y CAGREarnings
$700m
-19.0%
1y CAGR-7.6%
3y CAGR-13.8%
5y CAGREPS
$2.69
-19.2%
1y CAGR-8.2%
3y CAGR-14.3%
5y CAGRBook Value
$733m
$13.500b
Assets$12.767b
Liabilities$8.896b
DebtDebt to Assets
65.9%
5.9x
Debt to EBITDAFree Cash Flow
$323.224m
-45.0%
1y CAGR-3.6%
3y CAGR-22.3%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company